Stay updated on Pembrolizumab with Targeted Therapy Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.

Latest updates to the Pembrolizumab with Targeted Therapy Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no visible changes to study details or eligibility criteria.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision updated to v3.4.1, replacing the previous v3.4.0 label on the page.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision label on the page updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a Locations section with Arizona and Minnesota as study sites. Removed HHS Vulnerability Disclosure and the previous Arizona/Minnesota Location entries; page revision updated to v3.3.3.SummaryDifference0.3%

- Check92 days agoChange DetectedEditorial updates in Publications clarify that entries are automatically filled from PubMed and the page revision is now v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check99 days agoChange DetectedThe page removed the general funding-status notice related to government funding lapses. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab with Targeted Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.